Apollo Hospitals Enterprise Ltd

APOLLOHOSP

Watchlist

AI Mode

‌

Market Cap

₹ 1,01,920 Cr

P/E

60.96

‌

‌
‌

‌

‌
‌

Investment Checklist

How to read checklist?

Performance

STEADY PERFORMER

Valuation

REASONABLE

Growth

STABLE

Profitability

MODERATE MARGIN

Technicals

Bearish

Risk

MODERATE RISK

Investment Checklist

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

Price

PE Ratio

Price

‌

Overview

Detailed Summary

Apollo Hospitals Enterprise Limited is a leading private healthcare provider in Asia, with a network of hospitals, clinics, and pharmacies across India.

The company is undertaking a massive capacity expansion, planning to add 4,400 beds over the next five years in key metro areas, which will significantly enhance its healthcare infrastructure.

Apollo has strategically embraced AI technologies, developing tools with Microsoft to improve clinical outcomes and efficiency, demonstrating its commitment to technological innovation.

In Q2 FY26, Apollo reported a consolidated revenue growth of 13% year-on-year to INR 6,304 crore, with a notable 15% increase in EBITDA.

Apollo HealthCo, a subsidiary of Apollo Hospitals, continues to expand omni-channel healthcare services, achieving a 17% year-on-year revenue growth in Q2 FY26.

Sector

Healthcare

Industry

Hospitals / Medical Services

Market Cap

1,01,920 Cr

Volatility

Low Risk

P/E Ratio

61.0

Industry P/E

62.6

PEG Ratio

2.6

P/B Ratio

11.2

52W High

8,099.00

52W Low

6,002.15

Sales CAGR

14.35%

10.38%

-3.49%

10Y

4.36%

Profit CAGR

60.97%

31.31%

22.49%

10Y

16.26%

ROE

TTM

18.39%

14.06%

13.16%

10Y

11.19%

ROCE

TTM

16.07%

14.90%

14.25%

10Y

12.32%

Technicals

‌

Forecasts

No. of Analysts

32

1Y Price Target

9039.00 ▲ 28.19%

Q3 EPS Estimate

Q3 Revenue Estimate

Unlock Premium Features

Price, EPS and Revenue Projections

Strong SellSellHoldBuyStrong Buy

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

updated on

Dec 03, 2025

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
MAXHEALTH	1083.00	1,05,638 Cr	75.00	10.51	0.14	13.50	12.81	8.34
APOLLOHOSP	7089.10	1,01,920 Cr	60.96	11.22	0.18	18.39	16.07	7.88
FORTIS	866.30	65,651 Cr	65.19	6.96	0.12	10.75	12.26	6.91
NH	1899.85	38,825 Cr	45.66	9.56	0.24	20.82	17.75	10.92
ASTERDM	618.15	32,028 Cr	86.33	7.65	0.78	8.18	10.11	4.67
MEDANTA	1148.45	30,901 Cr	51.69	8.33	0.00	15.15	16.83	10.38
KIMS	673.35	26,839 Cr	81.70	11.82	0.00	14.80	10.88	5.37

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	4,418	4,847	4,851	4,944	5,086	5,589	5,527	5,592	5,842	6,304
Expenses	3,909	4,219	4,237	4,303	4,411	4,774	4,765	4,823	4,990	5,362
Operating Profit	509	627	614	640	675	816	762	770	852	941
OPM %	11.52	12.95	12.65	12.96	13.27	14.59	13.78	13.76	14.58	14.93
Other Income	34	26	29	37	49	44	69	72	54	61
Interest	106	111	113	119	116	118	110	115	108	110
Depreciation	167	163	167	190	177	185	185	211	215	218
Profit Before Tax	270	379	363	368	430	557	536	516	583	675
Tax %	35.78	34.35	29.98	29.82	26.63	29.01	29.24	19.59	24.32	26.78
Net Profit	173	249	254	258	316	396	379	415	441	494
EPS in Rs	11.59	16.20	17.06	17.65	21.23	26.34	25.89	27.10	30.10	33.19

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	7,256	8,243	9,617	11,247	10,560	14,663	16,613	19,059	21,794	22,551
Expenses	6,527	7,450	8,554	9,660	9,423	12,478	14,563	16,669	18,772	19,352
Operating Profit	729	793	1,064	1,587	1,137	2,185	2,050	2,391	3,022	3,199
OPM %	10.04	9.62	11.06	14.11	10.77	14.90	12.34	12.54	13.87	14.18
Other Income	65	32	32	225	106	372	90	108	233	238
Interest	257	295	327	533	449	379	381	449	459	450
Depreciation	314	359	396	620	573	601	615	687	758	795
Profit Before Tax	222	171	373	660	221	1,578	1,144	1,363	2,039	2,192
Tax %	40.96	65.27	46.54	34.12	38.38	30.23	22.40	32.70	26.19	25.60
Net Profit	131	60	199	435	136	1,101	888	917	1,505	1,631
EPS in Rs	—	—	16.64	31.64	10.56	73.42	56.96	62.50	100.56	116.28
Dividend Payout %	37.78	59.24	35.38	18.35	27.93	16.00	26.33	25.60	12.59	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	70	70	70	70	70	72	72	72	72	72
Reserves	3,262	3,244	3,182	3,264	3,270	4,531	5,551	6,126	6,864	8,140
Borrowings	2,633	3,024	3,303	3,450	3,350	4,160	4,068	4,332	5,333	7,864
Other Liabilities	1,396	1,782	2,058	2,400	4,650	2,654	3,578	3,898	4,485	4,581
Total Liabilities	7,360	8,119	8,613	9,183	11,338	11,417	13,269	14,428	16,753	20,657
Fixed Assets	3,997	4,583	4,766	4,975	7,426	6,773	8,291	8,516	9,661	10,985
CWIP	562	347	712	822	236	234	46	610	873	921
Investments	352	414	359	468	440	1,348	821	578	990	2,490
Other Assets	2,448	2,775	2,776	2,918	3,237	3,062	4,112	4,725	5,230	6,261
Total Assets	7,360	8,119	8,613	9,183	11,338	11,417	13,269	14,428	16,753	20,657

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	597	623	537	905	1,293	1,265	1,696	1,377	1,920	2,136
Cash from Investing Activity	-888	-1,152	-405	-711	-289	-880	-747	-857	-1,537	-3,381
Cash from Financing Activity	330	477	-108	-215	-910	-340	-792	-633	-311	1,317
Net Cash Flow	39	-52	24	-20	95	44	158	-113	72	73

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Promoters	29.33%	29.33%	29.33%	29.33%	29.33%	29.33%	29.33%	29.33%	29.33%	29.34%	29.34%	28.02%
FIIs	47.94%	46.96%	47.93%	46.15%	46.25%	45.63%	43.92%	45.37%	45.27%	42.74%	1.61%	44.20%
DIIs	16.78%	17.99%	17.24%	18.83%	19.10%	19.77%	21.37%	20.18%	20.20%	22.51%	21.57%	21.35%
Public	5.94%	5.71%	5.50%	5.69%	5.32%	5.26%	5.38%	5.12%	5.19%	5.41%	47.49%	6.43%
Total Shareholders	1,31,636	1,31,937	1,20,030	1,31,565	1,19,578	1,30,664	1,27,754	1,19,245	1,27,802	1,34,058	1,41,007	1,60,556

Market Transactions

Date	Party	Category	Type	Avg Price (₹)	Total Value (₹)	Quantity	Percent Traded
Nov 18, 2025	Suneeta reddy	Insider - Promoter & Director	Revoke	7,487.33	112.31 Cr	1,50,000	0.10
Oct 17, 2025	Pcr investments limited	Insider - Promoter	Revoke	785.70	180.71 Cr	23,00,000	1.59
Sep 30, 2025	K visweshwar reddy	Insider - Promoter	Pledge	7,444.29	52.11 Cr	70,000	0.04
Sep 12, 2025	Suneeta reddy	Insider - Promoter & Director	Revoke	7,879.43	137.89 Cr	1,75,000	0.12
Sep 10, 2025	K visweshwar reddy	Insider - Promoter	Revoke	7,845.08	219.62 Cr	2,79,946	0.19
Sep 05, 2025	Suneeta reddy	Insider - Promoter & Director	Revoke	7,736.00	444.82 Cr	5,75,000	0.39
Aug 30, 2025	Pcr investments limited	Insider - Promoter	Revoke	7,728.00	946.68 Cr	12,25,000	0.85
Aug 30, 2025	K vishweshwar reddy	Insider - Promoter	Pledge	7,610.00	83.71 Cr	1,10,000	0.07
Aug 26, 2025	Suneeta reddy	Insider - Promoter & Director	Disposal	7,818.84	1,483.42 Cr	18,97,239	1.31
Aug 22, 2025	Invesco mutual fund	Block	Buy	7,850.00	5.71 Cr	7,280	0.00

Projection

Unlock Premium Features

Get In-depth insights on EPS and Revenue forecasts

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

Documents

Presentations

Concalls

Reports

Presentations

Investor Presentation

Q2 FY26

Investor Presentation

Q1 FY26

Investor Presentation

Q4 FY25

Investor Presentation

Q3 FY25

Investor Presentation

Q2 FY25

Investor Presentation

Q1 FY25

Investor Presentation

Q4 FY24

Investor Presentation

Q4 FY24

Showing 1 - 8 of 24

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

AI Mode

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	4,418	4,847	4,851	4,944	5,086	5,589	5,527	5,592	5,842	6,304
Expenses	3,909	4,219	4,237	4,303	4,411	4,774	4,765	4,823	4,990	5,362
Operating Profit	509	627	614	640	675	816	762	770	852	941
OPM %	11.52	12.95	12.65	12.96	13.27	14.59	13.78	13.76	14.58	14.93
Other Income	34	26	29	37	49	44	69	72	54	61
Interest	106	111	113	119	116	118	110	115	108	110
Depreciation	167	163	167	190	177	185	185	211	215	218
Profit Before Tax	270	379	363	368	430	557	536	516	583	675
Tax %	35.78	34.35	29.98	29.82	26.63	29.01	29.24	19.59	24.32	26.78
Net Profit	173	249	254	258	316	396	379	415	441	494
EPS in Rs	11.59	16.20	17.06	17.65	21.23	26.34	25.89	27.10	30.10	33.19

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	7,256	8,243	9,617	11,247	10,560	14,663	16,613	19,059	21,794	22,551
Expenses	6,527	7,450	8,554	9,660	9,423	12,478	14,563	16,669	18,772	19,352
Operating Profit	729	793	1,064	1,587	1,137	2,185	2,050	2,391	3,022	3,199
OPM %	10.04	9.62	11.06	14.11	10.77	14.90	12.34	12.54	13.87	14.18
Other Income	65	32	32	225	106	372	90	108	233	238
Interest	257	295	327	533	449	379	381	449	459	450
Depreciation	314	359	396	620	573	601	615	687	758	795
Profit Before Tax	222	171	373	660	221	1,578	1,144	1,363	2,039	2,192
Tax %	40.96	65.27	46.54	34.12	38.38	30.23	22.40	32.70	26.19	25.60
Net Profit	131	60	199	435	136	1,101	888	917	1,505	1,631
EPS in Rs	—	—	16.64	31.64	10.56	73.42	56.96	62.50	100.56	116.28
Dividend Payout %	37.78	59.24	35.38	18.35	27.93	16.00	26.33	25.60	12.59	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	70	70	70	70	70	72	72	72	72	72
Reserves	3,262	3,244	3,182	3,264	3,270	4,531	5,551	6,126	6,864	8,140
Borrowings	2,633	3,024	3,303	3,450	3,350	4,160	4,068	4,332	5,333	7,864
Other Liabilities	1,396	1,782	2,058	2,400	4,650	2,654	3,578	3,898	4,485	4,581
Total Liabilities	7,360	8,119	8,613	9,183	11,338	11,417	13,269	14,428	16,753	20,657
Fixed Assets	3,997	4,583	4,766	4,975	7,426	6,773	8,291	8,516	9,661	10,985
CWIP	562	347	712	822	236	234	46	610	873	921
Investments	352	414	359	468	440	1,348	821	578	990	2,490
Other Assets	2,448	2,775	2,776	2,918	3,237	3,062	4,112	4,725	5,230	6,261
Total Assets	7,360	8,119	8,613	9,183	11,338	11,417	13,269	14,428	16,753	20,657

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	597	623	537	905	1,293	1,265	1,696	1,377	1,920	2,136
Cash from Investing Activity	-888	-1,152	-405	-711	-289	-880	-747	-857	-1,537	-3,381
Cash from Financing Activity	330	477	-108	-215	-910	-340	-792	-633	-311	1,317
Net Cash Flow	39	-52	24	-20	95	44	158	-113	72	73

Overview

Detailed Summary

Apollo Hospitals Enterprise Limited is a leading private healthcare provider in Asia, with a network of hospitals, clinics, and pharmacies across India.

The company is undertaking a massive capacity expansion, planning to add 4,400 beds over the next five years in key metro areas, which will significantly enhance its healthcare infrastructure.

Apollo has strategically embraced AI technologies, developing tools with Microsoft to improve clinical outcomes and efficiency, demonstrating its commitment to technological innovation.

In Q2 FY26, Apollo reported a consolidated revenue growth of 13% year-on-year to INR 6,304 crore, with a notable 15% increase in EBITDA.

Apollo HealthCo, a subsidiary of Apollo Hospitals, continues to expand omni-channel healthcare services, achieving a 17% year-on-year revenue growth in Q2 FY26.

Sector

Healthcare

Industry

Hospitals / Medical Services

Market Cap

1,01,920 Cr

Volatility

Low Risk

P/E Ratio

61.0

Industry P/E

62.6

PEG Ratio

2.6

P/B Ratio

11.2

52W High

8,099.00

52W Low

6,002.15

Sales CAGR

14.35%

10.38%

-3.49%

10Y

4.36%

Profit CAGR

60.97%

31.31%

22.49%

10Y

16.26%

ROE

TTM

18.39%

14.06%

13.16%

10Y

11.19%

ROCE

TTM

16.07%

14.90%

14.25%

10Y

12.32%